Center for Healthy Minds, University of Wisconsin-Madison.
Department of Counseling Psychology, University of Wisconsin-Madison.
Perspect Psychol Sci. 2022 Jan;17(1):108-130. doi: 10.1177/1745691620968771. Epub 2021 Feb 16.
In response to questions regarding the scientific basis for mindfulness-based interventions (MBIs), we evaluated their empirical status by systematically reviewing meta-analyses of randomized controlled trials (RCTs). We searched six databases for effect sizes based on four or more trials that did not combine passive and active controls. Heterogeneity, moderators, tests of publication bias, risk of bias, and adverse effects were also extracted. Representative effect sizes based on the largest number of studies were identified across a wide range of populations, problems, interventions, comparisons, and outcomes (PICOS). A total of 160 effect sizes were reported in 44 meta-analyses ( = 336 RCTs, = 30,483 participants). MBIs showed superiority to passive controls across most PICOS (s = 0.10-0.89). Effects were typically smaller and less often statistically significant compared with active controls. MBIs were similar or superior to specific active controls and evidence-based treatments. Heterogeneity was typically moderate. Few consistent moderators were found. Results were generally robust to publication bias, although other important sources of bias were identified. Reporting of adverse effects was inconsistent. Statistical power may be lacking in meta-analyses, particularly for comparisons with active controls. Because MBIs show promise across some PICOS, future RCTs and meta-analyses should build on identified strengths and limitations of this literature.
针对有关正念干预(MBI)的科学基础的问题,我们通过系统地综述随机对照试验(RCT)的荟萃分析来评估其经验状况。我们在六个数据库中搜索了基于四个或更多未将被动和主动对照相结合的试验的效应量。还提取了异质性、调节因素、发表偏倚检验、偏倚风险和不良反应。基于研究数量最多的代表性效应量在广泛的人群、问题、干预、比较和结果(PICOS)范围内确定。44 项荟萃分析报告了 160 个效应量(=336 项 RCT,=30483 名参与者)。MBI 在大多数 PICOS 中均优于被动对照(s=0.10-0.89)。与主动对照相比,这些效应通常较小,且不太经常具有统计学意义。MBI 与特定的主动对照和循证治疗相似或优于后者。异质性通常为中度。发现的调节因素很少且一致。结果通常对发表偏倚具有稳健性,尽管还发现了其他重要的偏倚来源。不良反应的报告不一致。荟萃分析可能缺乏统计能力,尤其是对于与主动对照的比较。由于 MBI 在某些 PICOS 中显示出前景,因此未来的 RCT 和荟萃分析应在该文献的确定优势和局限性的基础上进行。